GSK abandons malaria drugs

pharmafile | March 4, 2008 | News story | Sales and Marketing reg, safety 

Related Content

eisa0008_web

Eisai’s weight loss drug lorcaserin found safe in major study

Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according …

fda_sign_web

FDA announces strongest warnings for opioid pain medications

The US Food and Drug Administration has announced class-wide safety labelling changes for immediate release …

FDA sign

FDA criticised for safety data flaws

The US FDA is failing to meet its ‘statutorily required’ obligations to track safety data …

Latest content